Shares of AtriCure Inc. (ATRC) have plummeted a staggering 63% from their 52-week high of $59.61, reached in July of last year, and currently trade around the $21 level.
This medical device company offers surgical treatments and therapies for atrial fibrillation (Afib) and reduction of Afib related complications. Isolator Synergy Ablation System, AtriClip Left Atrial Appendage Exclusion System products, EPi-Sense Systems for Hybrid AF Therapy and cryoICE cryoSPHERE probe are some of the company's marketed products.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com